BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg

    PMA: P970054 · Supplement: S022 · Decision Jan 6, 2025
    View on FDA
    Classifications
    1
    FEI Numbers
    4
    Registration Numbers
    4

    Basic Information

    Device Name
    Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg
    Trade Name
    Parvovirus B 19 IgG Enzyme Immunoassay
    PMA Number
    P970054
    Supplement Number
    S022
    Device Class
    FDA Class 3
    Product Code
    MYL
    Generic Name
    ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG
    Medical Specialty
    Unknown
    Advisory Committee
    Microbiology
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    January 6, 2025
    Date Received
    December 10, 2024
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    a new piece of equipment required for manufacturing

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MYL Assay,Enzyme Linked Immunosorbent,Parvovirus B19 Igg